Skip to Content


Foreign-Trade Zone 93-Raleigh/Durham, North Carolina, Authorization of Production Activity, GlaxoSmithKline, PLC (Pharmaceutical Products), Zebulon, North Carolina

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

On November 18, 2013, the Triangle J Council of Governments, grantee of FTZ 93, submitted a notification of proposed production activity to the Foreign-Trade Zones (FTZ) Board on behalf of GlaxoSmithKline, PLC, within FTZ 93—Site 6, in Zebulon, North Carolina.

The notification was processed in accordance with the regulations of the FTZ Board (15 CFR part 400), including notice in the Federal Register inviting public comment (78 FR 70531-70532, 11-26-2013). The FTZ Board has determined that no further review of the activity is warranted at this time. The production activity described in the notification is authorized, subject to the FTZ Act and the Board's regulations, including Section 400.14.

Start Signature

Dated: March 18, 2014.

Andrew McGilvray,

Executive Secretary.

End Signature End Preamble

[FR Doc. 2014-06707 Filed 3-25-14; 8:45 am]